Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

1,123 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS ▴
PLRX	Pliant Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$149.34M	n/a	-82.4%	n/a	-$2.43
FDMT	4D Molecular Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$85.21M	-$140.11M	-164.4%	-27.7%	n/m	-$2.42
ARCT	Arcturus Therapeutics Holdings Inc. Manufacturing · Year ended 2025-12-31 · USD	$82.03M	-$65.78M	-80.2%	-30.7%	-46.1%	-$2.40
MBX	MBX Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$86.97M	n/a	-23.6%	n/a	-$2.38
RGC	Regencell Bioscience Holdings Ltd Manufacturing · Year ended 2026-06-30 · USD	n/a	-$11.70M	n/a	-87.7%	n/a	-$2.37
MGX	Metagenomi Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$25.21M	-$87.87M	-348.5%	-55.4%	-51.8%	-$2.36
BLTE	Belite Bio, Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$77.61M	n/a	-10.1%	n/a	-$2.31
FTFT	Future FinTech Group Inc. Services · Year ended 2025-12-31 · USD	$3.83M	-$4.62M	-120.6%	-10.5%	81.1%	-$2.31
RDW	Redwire Corp Manufacturing · Year ended 2025-12-31 · USD	$335.38M	-$226.55M	-67.6%	-21.4%	10.3%	-$2.28
CAPR	Capricor Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$105.04M	n/a	-34.4%	-100.0%	-$2.26
AZTR	Azitra, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$10.96M	n/a	-288.2%	-100.0%	-$2.25
BIOA	BioAge Labs, Inc. Manufacturing · Year ended 2025-12-31 · USD	$8.99M	-$80.61M	-896.1%	-29.6%	n/a	-$2.24
EBON	Ebang International Holdings Inc. Finance & Real Estate · Year ended 2025-12-31 · USD	$6.54M	-$14.09M	-215.6%	-5.8%	11.4%	-$2.24
BLNE	Beeline Holdings, Inc. Finance & Real Estate · Year ended 2025-12-31 · USD	$7.77M	-$23.17M	-298.2%	-43.2%	600.0%	-$2.23
AEI	Alset Inc. Finance & Real Estate · Year ended 2025-12-31 · USD	$4.47M	-$47.41M	n/m	-39.2%	-78.8%	-$2.22
TCRT	Alaunos Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$5.0K	-$4.18M	n/m	-194.0%	-50.0%	-$2.20
ANRO	Alto Neuroscience, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$63.24M	n/a	-41.8%	n/a	-$2.19
SLGL	Sol-Gel Technologies Ltd. Manufacturing · Year ended 2025-12-31 · USD	$19.39M	-$6.13M	-31.6%	-26.9%	68.0%	-$2.19
CTNM	Contineum Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$59.98M	n/a	-23.0%	n/a	-$2.17
MGRX	Mangoceuticals, Inc. Services · Year ended 2025-12-31 · USD	$456.0K	-$20.64M	n/m	-135.8%	-26.0%	-$2.17
SMR	Nuscale Power Corp Manufacturing · Year ended 2025-12-31 · USD	$31.48M	-$355.79M	n/m	-30.4%	-15.0%	-$2.17
COGT	Cogent Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$328.94M	n/a	-51.7%	n/a	-$2.16
AVX	Avax One Technology Ltd. Finance & Real Estate · Year ended 2025-12-31 · USD	$2.34M	-$33.20M	n/m	-17.8%	n/m	-$2.15
CARL	Carlsmed, Inc. Manufacturing · Year ended 2025-12-31 · USD	$50.51M	-$29.63M	-58.7%	-30.0%	85.9%	-$2.12
PEPG	PepGen Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$89.66M	n/a	-60.8%	n/a	-$2.12

Rows per page: 2550 100